CALGARY, ALBERTA--(Marketwire - Oct. 15, 2007) - Stem Cell Therapeutics Corp. (“SCT”) (TSX VENTURE:SSS) is pleased to announce the appointment of Mr. Scott Tannas, a senior financial and insurance brokerage executive, to the Board of Directors. SCT also announces that Dr. J.P. Castaigne has resigned from SCT’s Board of Directors in order to focus on his current obligations at Angiochem Inc.